Changes in Cardiovascular Health Status and the Risk of New-Onset Hypertension in Kailuan Cohort Study

被引:5
|
作者
Gao, Fei [1 ]
Liu, Xiaoxue [2 ]
Wang, Xizhu [2 ]
Chen, Shouhua [3 ]
Shi, Jihong [4 ]
Zhang, Ying [5 ]
Wu, Shouling [4 ]
Cai, Jun [6 ,7 ]
机构
[1] Univ Hong Kong, LKS Fac Med, Dept Opthalmol, Hong Kong, Hong Kong, Peoples R China
[2] North China Univ Sci & Technol, Tangshan Peoples Hosp, Dept Cardiol, Tangshan, Peoples R China
[3] North China Univ Sci & Technol, Kailuan Hosp, Dept Hlth Care Ctr, Tangshan, Peoples R China
[4] North China Univ Sci & Technol, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China
[5] North China Univ Sci & Technol, Hosp, Dept Ultrasonog, Tangshan, Peoples R China
[6] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Dept Hyertens, Beijing, Peoples R China
[7] Peking Union Med Coll, Beijing, Peoples R China
来源
PLOS ONE | 2016年 / 11卷 / 07期
关键词
C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; URIC-ACID LEVELS; ASSOCIATION; PREVALENCE; INFLAMMATION; POPULATION; MORTALITY; METRICS; IMPACT;
D O I
10.1371/journal.pone.0158869
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
American Heart Association cardiovascular health metrics are intimately related to cardiovascular diseases. Acting as a key independent risk factor for high morbidity and mortality of cardiovascular diseases, hypertension and its relationship between health status get urgent attention. While the influence of individual health status changes and the future risk of new-onset hypertension is rarely understood, the present study applied this construct to assess the changes of cardiovascular health status and the morbidity of hypertension in Kailuan cohort study in north China. The Cardiovascular Health Score (CHS) was evaluated by the follow-ups of 2006-2007, 2008-2009, 2010-2011 and 2012-2013. The study population (n = 19381) was divided into 5 groups based on the changes in their CHS score between the first two follow-ups (Delta CHS) of 2006-2007 and 2008-2009 (<=-2, -1, 0, 1, >= 2). The morbidity of hypertension was collected during 2010-2011 and 2012-2013 follow-ups. Data analysis showed that during a median follow-up of 3.79 +/- 0.96 years, morbidity of hypertension had a graded relationship with Delta CHS. As Delta CHS scored from low to high, the standardized morbidity of hypertension for all participants were 81.40, 75.47, 68.37, 71.43 and 83.13 per 1000 person-year, respectively. An increased Delta CHS score of 1 was associated with a 10% decrease in the future risk of new-onset hypertension(HR: 0.90, 95% CI: 0.88-0.92). In conclusion, there was a strong inverse relationship between the incidence of new-onset hypertension and elevation of cardiovascular health metrics. Population-wide prevention, especially the promotion of lifestyle improvements, is critical to reducing the morbidity of new-onset hypertension.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Combined effect of triglyceride glucose-body mass index and hypertension on new-onset stroke: evidence from the China health and retirement longitudinal study
    Ma, Fucun
    Hu, Jiaying
    Gao, Zheng
    Liu, Xuekai
    Bai, Mingjian
    Liang, Guowei
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [32] Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation
    Conen, David
    Wong, Jorge A.
    Sandhu, Roopinder K.
    Cook, Nancy R.
    Lee, I-Min
    Buring, Julie E.
    Albert, Christine M.
    JAMA CARDIOLOGY, 2016, 1 (04) : 389 - 396
  • [33] A prospective study of waist circumference trajectories and incident cardiovascular disease in China: the Kailuan Cohort Study
    Wang, Liang
    Lee, Yujin
    Wu, Yuntao
    Zhang, Xinyuan
    Jin, Cheng
    Huang, Zhe
    Wang, Yixin
    Wang, Zhiyi
    Kris-Etherton, Penny
    Wu, Shouling
    Gao, Xiang
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2021, 113 (02) : 338 - 347
  • [34] Associations between whole grains intake and new-onset hypertension: a prospective cohort study
    Xu, Zi-Hao
    Tang, Xu-Lian
    Qiu, Cheng-Shen
    Li, Hong-Min
    Liao, Dan-Qing
    Du, Li-Ying
    Lai, Shu-Min
    Huang, Hong-Xuan
    Xiong, Zhi-Yuan
    Li, Xiao-Ning
    Zhao, Li-Na
    Li, Zhi-Hao
    EUROPEAN JOURNAL OF NUTRITION, 2024, 63 (07) : 2437 - 2447
  • [35] Dietary Iron Intake and New-Onset Hypertension: A Nationwide Cohort Study from China
    Zhang, Z.
    Liu, C.
    Liu, M.
    Zhou, C.
    Li, Q.
    He, P.
    Zhang, Y.
    Li, H.
    Qin, X.
    JOURNAL OF NUTRITION HEALTH & AGING, 2022, 26 (11) : 1016 - 1024
  • [36] Changes in Physical Activity and the Risk of Dementia in Patients With New-Onset Type 2 Diabetes: A Nationwide Cohort Study
    Yoo, Jung Eun
    Han, Kyungdo
    Kim, Bongseong
    Park, Sang-Hyun
    Kim, Seon Mee
    Park, Hye Soon
    Nam, Ga Eun
    DIABETES CARE, 2022, 45 (05) : 1091 - 1098
  • [37] The effects of hypertension and diabetes on new-onset chronic kidney disease: A prospective cohort study
    Wang, Miao
    Li, Junjuan
    Li, Yao
    Yao, Siyu
    Zhao, Maoxiang
    Wang, Chi
    Wu, Shouling
    Xue, Hao
    JOURNAL OF CLINICAL HYPERTENSION, 2020, 22 (01) : 39 - 46
  • [38] Childhood Parental Incarceration and Adult-Onset Hypertension and Cardiovascular Risk
    Tung, Elizabeth L.
    Wroblewski, Kristen E.
    Makelarski, Jennifer A.
    Glasser, Nathaniel J.
    Lindau, Stacy Tessler
    JAMA CARDIOLOGY, 2023, 8 (10) : 927 - 935
  • [39] A Cohort Study on the Correlation Between Serum Uric Acid Trajectory and New-Onset Hypertension Based on Longitudinal Health Examination Data in Henan Area
    Sheng, Shifeng
    Chen, Jingfeng
    Zhang, Yuheng
    Li, Weikang
    Li, Feifei
    Gou, Rong
    Tang, Lin
    Ding, Suying
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 1365 - 1375
  • [40] Association of Age of Metabolic Syndrome Onset With Cardiovascular Diseases: The Kailuan Study
    Huang, Zegui
    Wang, Xianxuan
    Ding, Xiong
    Cai, Zefeng
    Li, Weijian
    Chen, Zekai
    Fang, Wei
    Cai, Zhiwei
    Lan, Yulong
    Chen, Guanzhi
    Wu, Weiqiang
    Chen, Zhichao
    Wu, Shouling
    Chen, Youren
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13